Yamana H, Tashiro-Yamaji J, Hayashi M, Maeda S, Shimizu T, Tanigawa N, Uchiyama K, Kubota T, Yoshida R
Department of Physiology, Osaka Medical College, Takatsuki, Japan; Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Japan.
Clin Exp Immunol. 2014 Oct;178(1):118-28. doi: 10.1111/cei.12383.
Mouse monocyte/macrophage major histocompatibility complex (MHC) receptor 1 (MMR1; or MMR2) specific for H-2D(d) (or H-2K(d) ) molecules is expressed on monocytes from non-H-2D(d) (or non-H-2K(d) ), but not those from H-2D(d) (or H-2K(d) ), inbred mice. The MMR1 and/or MMR2 is essential for the rejection of H-2D(d) - and/or H-2K(d) -transgenic mouse skin onto C57BL/6 (H-2D(b) K(b) ) mice. Recently, we found that human leucocyte antigen (HLA)-B44 was the sole ligand of human MMR1 using microbeads that had been conjugated with 80 types of HLA class I molecules covering 94·2% (or 99·4%) and 92·4% (or 96·2%) of HLA-A and B molecules of Native Americans (or Japanese), respectively. In the present study, we also explored the ligand specificity of human MMR2 using microbeads. Microbeads coated with HLA-A32, HLA-B13 or HLA-B62 antigens bound specifically to human embryonic kidney (HEK)293T or EL-4 cells expressing human MMR2 and to the solubilized MMR2-green fluorescent protein (GFP) fusion protein; and MMR2(+) monocytes from a volunteer bound HLA-B62 molecules with a Kd of 8·7 × 10(-9) M, implying a three times down-regulation of MMR2 expression by the ligand expression. H-2K(d) (or H-2D(d) ) transgene into C57BL/6 mice down-regulated not only MMR2 (or MMR1) but also MMR1 (or MMR2) expression, leading to further down-regulation of MMR expression. In fact, monocytes from two (i.e. MMR1(+) /MMR2(+) and MMR1(-) /MMR2(-) ) volunteers bound seven to nine types of microbeads among 80, indicating ≤ 10 types of MMR expression on monocytes. The physiological role of constitutive MMRs on monocytes possibly towards allogeneic (e.g. fetal) cells in the blood appears to be distinct from that of inducible MMRs on macrophages toward allografts in tissue.
对H-2D(d)(或H-2K(d))分子具有特异性的小鼠单核细胞/巨噬细胞主要组织相容性复合体(MHC)受体1(MMR1;或MMR2)在非H-2D(d)(或非H-2K(d))近交系小鼠的单核细胞上表达,而在H-2D(d)(或H-2K(d))近交系小鼠的单核细胞上不表达。MMR1和/或MMR2对于将H-2D(d)和/或H-2K(d)转基因小鼠皮肤排斥到C57BL/6(H-2D(b)K(b))小鼠身上至关重要。最近,我们使用与80种I类HLA分子偶联的微珠发现,人类白细胞抗原(HLA)-B44是人类MMR1的唯一配体,这些微珠分别覆盖了94.2%(或99.4%)和92.4%(或96.2%)的美洲原住民(或日本人)的HLA-A和B分子。在本研究中,我们还使用微珠探索了人类MMR2的配体特异性。包被有HLA-A32、HLA-B13或HLA-B62抗原的微珠特异性结合表达人类MMR2的人类胚胎肾(HEK)293T或EL-4细胞以及可溶性MMR2-绿色荧光蛋白(GFP)融合蛋白;一名志愿者的MMR2(+)单核细胞以8.7×10(-9) M的解离常数结合HLA-B62分子,这意味着配体表达使MMR2表达下调了三倍。将H-2K(d)(或H-2D(d))转基因导入C57BL/6小鼠不仅下调了MMR2(或MMR1)的表达,还下调了MMR1(或MMR2)的表达,导致MMR表达进一步下调。事实上,两名志愿者(即MMR1(+) /MMR2(+)和MMR1(-) /MMR2(-))的单核细胞在80种微珠中结合了7至9种,表明单核细胞上MMR的表达≤10种。单核细胞上组成型MMR对血液中同种异体(如胎儿)细胞的生理作用似乎与巨噬细胞上诱导型MMR对组织中同种异体移植物的生理作用不同。